Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That action would allow the POM-POMS to continue to mislead investors about this Company.
Don't Go!! You're doing a service.
Pura Vida!!
FROM 10K, a working capital deficit of $10.5 million
Fri, May 17, 4:32 PM (9 days ago)
Avenir Wellness Solutions, Inc. (AVRW), a Delaware-based technology company, focuses on nutraceutical formulation and delivery technologies. For the fiscal year ended December 31, 2023, the company reported a decrease in revenue to $4.3 million from $4.9 million in 2022, primarily due to limited marketing capabilities and the discontinuation of certain product lines. Cost of goods sold decreased to $1.2 million, reflecting a 28.5% revenue share, down from 31.8% in 2022, mainly due to reduced inventory reserves. Operating expenses totaled $9.1 million, down from $11.7 million in 2022, driven by lower depreciation, amortization, and professional fees. The company reported a significant improvement in other income, primarily due to gains from debt extinguishment and changes in the fair value of convertible notes. However, the company still faces a substantial working capital deficit of $10.5 million. Avenir's future outlook includes continued efforts to grow its product offerings and customer base, with a focus on improving cash flow from operations. The company acknowledges the need for additional funding to sustain operations and address its working capital deficit. Risk factors include reliance on additional capital, market conditions, and supply chain disruptions.
https://tradepost.ai/analysis/avenir-wellness-solutions-inc-avrw-10-k-filing-2023
A CEO WHO IS NOT WORRIED ABOUT STOCK PRICE.
In January of 2023, Nancy Duitch basically said the same thing as now.
And, what has the stock done - especially since she publicly said she
wasn't going to worry about the stock price - GEESH - unheard of - not worried
about the stock price - thus - not worried about shareholders.
Share price went from 20 cents per share down to 3 cents with
a low of 2 cents.
From Nancy Duitch interview:
Avenir’s stock is only worth 20 cents as of Jan. 18, but with a new direction that could change.
An expert in the wellness industry, Duitch is ready and excited for this new chapter in Avenir’s history.
“I made a decision that I wasn’t going to worry about the stock, I was going to
worry about building the foundation of the company and the fundamentals of the company and we put
together a phenomenal team once I got money in from the sale,” Duitch said.
“I’m very frugal with money but I brought in some great people on the team that have really been so
phenomenal. It took us four or five months to find the right people and get the right team together and
really get things going but I am excited and optimistic about 2023.”
https://www.pacbiztimes.com/2023/01/19/a-fresh-face-avenir-formerly-cure-embraces-rebrand/
Funny she says she is very frugal with money when she burnt through that money in record time......
And what did that optimism about 2023 with all the big talk get shareholder's - more debt and a huge
drop in the stock price. So, the big talk about 2024 that is being talked about - with them being even
more in debt and no one to loan them any money ??
Talk is talk and just that...... ALL TALK
NICOLE KIDMAN JOINS - STOCK DROPS 98% LOL
Since teaming up with SeraLabs in Dec of 2020, the
stock price has dropped from $1.83 per share to 3 cents.
Even she can't save this company with a bad business model
and even worse management and BOD's. They have absolutely
no idea how to run a publicly traded company. As well, they have
no money, no credit, no profits and defaulted debt currently in litigation.
They can't issue stock, no bank will touch them, and no other
financial investor's or institutions will even consider them.
Add it all up - BANKRUPTCY is the ONLY way out.
AVRW - A COMPANY SOON TO BE BANKRUPT.
As clearly detailed in the AVRW news from May 17th, the company is growing sales and revenues as well as lowering its operating costs. This the the formula for success and AVRW is on track for a positive year in 2024. And, of course, all information in official news from the company is accountable to the SEC and therefore credible information. Off-handed comments by any anonymous posters on chat boards are accountable to no one and therefore have no credibility.
Avenir Wellness Solutions Reports Fourth Quarter 2023 Results
New Initiatives Showing Encouraging Results
SHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended December 30, 2023.
Key financial highlights for the fourth quarter included the following:
Net revenue in the fourth quarter of 2023 increased to $1.1 million from the same period in 2022 by $0.2 million, or 11.7%, and also increased sequentially from Q3 2023 by $43 thousand, or 4.4%. Overall growth was lower than expected due to the continued delay in receiving the expected remainder of the asset sale proceeds to be used for advertising and marketing to drive sales. The quarter did, however, benefit from a new relationship with leading online and beauty subscription box retailer, FabFitFun.
Gross margin increased 407 basis points year over year in the fourth quarter of 2023 due to improved working capital management offset in part by a higher proportion of sales coming from our wholesale channel of distribution with its lower margins than our higher-margin direct-to-consumer sales channel.
Gross margin for the third quarter of 2023 decreased sequentially from the second quarter of 2023 by 26 basis points due to a shift in sales channel mix with a higher proportion of wholesale sales to Amazon and FabFitFun which resulted in shipments of approximately $0.3 million.
Cost containment initiatives led to a favorable impact on SG&A expenses (excluding non-cash charges) for the fourth quarter with a decrease of $357 thousand in 2023 compared to 2022 driven by decreased spend on advertising and promotion of $325 thousand lower overhead by $32 thousand.
Net operating loss from continuing operations (excluding non-cash charges) improved by $0.9 million in 2023.
"Our products continue to maintain sales levels which is encouraging given that we have been unable to fully execute on our marketing initiatives pending receipt of the balance of the proceeds from the July 2022 asset sale. As mentioned in our third quarter earnings announcement, the proceeds from the July 2022 asset sale allow us to invest in the future of the Company, but the delay in receiving the balance of the proceeds continued to have an impact on our operating performance. We expect accelerating sales will reaffirm the improving overall trajectory of the business. Further, our margin expansion initiatives continue to deliver results with improvement from third quarter, and we continue our overall cost containment initiatives to further reduce SG&A expenses and to maximize operating leverage.
Fine tuning our Search Engine Optimization (SEO), bringing our media buying in house and achieving successful monthly campaigns like theSkimm continue to deliver for us as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.
Operational Highlights
Other operational highlights during the fourth quarter of 2023 included:
Our newly formulated Seratopical Revolution Cracked Heel Souffle was selected for inclusion in FatFitFun's Summer 2024 subscription box selling out an astonishing 80,000 units in under 43 minutes. Click link to view Instagram videos on our Cracked Heel Souffle.
Our DNA Complex hero product continues to perform as our subscription based grows.
Wholesale sales led by Amazon continue to grow with all the positive product reviews.
We began development of our new TikTok shop to capitalize on the evolving digital ecommerce landscape which launched in the second quarter of 2024.
For further details, please visit our website to review our most recent Form 10-K filed on May 17, 2024 at: http://www.avenirwellness.com/sec-filings/
About Avenir Wellness Solutions, Inc.
Avenir Wellness Solutions, Inc. (OTCQB:AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems which are integrated into our wellness and beauty products and sold directly to the consumer. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that is part of its incubator strategy in order to monetize its intellectual property as well as expand our product lines utilizing the technology. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: http://www.avenirwellness.com.
About The Sera Labs, Inc.
Sera Labs, a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health and wellness, Sera Labs products are sold direct-to-consumer (DTC) via online website orders, including a subscribe and save option, and also sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers and on Amazon.com. For more information visit: http://www.seralabshealth.com and follow Sera Labs on Facebook, Instagram and TikTok at @seratopical as well as on X (Twitter) at @sera_labs.
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.
CONTACTS:
Investor Relations
Hanover International Inc.
T: (760) 564-7400
E: investor@avenirwellness.com
SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)
View the original press release on accesswire.com
This Company generates sales by spending MONEY for advertising. No advertising = NO SALES.
Where is the MONEY for advertising going to come from?
The IONIC DEFAULTED DEBT means no investment bank could raise Avenir any capital. Nancy is using her credit card to fund operations, but she has only a limited line of credit.
Rob Davidson got this Company into the IONIC DEBT pit and it can't get out. He is also the CEO of the Company that took the Crown Jewel patents from Avenir as he remains Chairman of Avenir; a real conflict of interest!
PURA VIDA!!
It will take 3 THINGS to get this company over the hump:
NUMBER 1: SALES
NUMBER 2: SALES
NUMBER 3: SALES
Happy Memorial Day Weekend Everybody!!
I have followed this company longer than anyone else posting here.
I tend to know what the hell has gone on here. As well - once again....
REAL INVESTOR'S aren't even looking at this POS company.
Anyone who thinks I am just posting here just recently, go back 7 years and
you will see that I followed this company, and was actually invested until she
dropped below $1.00 and I started putting the RD pieces of the puzzle together
and through my buddy heard some pretty damning things before he died down
HUGE money on this by trusting in RD. I told him he was asking for trouble, but
he just kept putting money in. Believe it or not - long before SeraLabs and Avenir
Wellness (before the IONIC dilutive debt debacle to acquire SeraLabs) I was
bullish.
Anyhow, I think I know what the hell I am talking about here. Been watching it for
a LONG LONG TIME and have done more research most likely - than all the rest
of the BULLISH people posting here combined. Just a response to some bullshit I just read.
As far as an OTCQB company being under any true scrutiny of the SEC, that is a
real freaking JOKE. I mean LOL !! The company can state all kind of lies, and
RD has truly done so - and he's still COB of this failing company.
And - bid and ask prices are dropping again after some read the quite late 10K
Everyone - have a truly nice Memorial Day Weekend !!
The new AVRW feature article is clearly sourced entirely from official news that has been issued directly from the company. This completely validates its content material. As a fully reporting OTCQB listed equity, AVRW management is 100% accountable to the SEC for accuracy and truthfulness in everything they state in any public announcement. This is why the article has credibility, of course. Anonymous persons posting off-handed comments on chat boards have zero accountability to anyone and therefore zero credibility. Real investors know this.
Avenir Wellness / Sera Labs Inc. Partnership with Nicole Kidman - FabFitFun and Influencer Endorsements Drive Sales Growth for Seratoptical Revolutions Skin : Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW)
https://www.einpresswire.com/article/711238053/solid-growth-for-seratoptical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw
I guess if POM-POMS want to repeat this BS PAID FOR "article; I will repeat my response......
Again; POM-POMS deceiving us with their posts...
This is a "PAID-FOR" article. Read the disclaimer at the bottom which our POM-POMS refer to as media exposure...DISCLAIMER: https://corporateads.com/disclaimer/
$AVRW Avenir Wellness Solutions / Sera Labs Inc. Partnership with Nicole Kidman - FabFitFun and Influencer Endorsements Drive Sales Growth for Seratoptical Revolutions Skin : Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW)
https://www.einpresswire.com/article/711238053/solid-growth-for-seratoptical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw
Right - "REAL INVESTORS" want to know 🤣😂😭
Real investors go through 10Ks and 10Qs carefully.
Real investors won't touch this penny stock, period.
Real investors don't get sucked in by Fluff paid for
articles from unreputable sources.
And as for the "many key celebrities", Nicole Kidman
has been with the company since Dec 2020 when the
stock price was approx. $1.83 per share. It's between
3 cents and 4 cents now - so truly, not too many people
care.
Again; POM-POMS deceiving us with their posts...
This is a "PAID-FOR" article. Read the disclaimer at the bottom which our POM-POMS refer to as media exposure...DISCLAIMER: https://corporateads.com/disclaimer/
JediJazz….hardly worth mentioning until we see “30 day daily average volume” of 100,000 share traded every day!! It will take brokerage firms getting on board and recommending Avenir shares to potential investors.
The 22,000 shares today only amounts to $800.00 of buying and selling. Without the support of brokerage firms recommending Avenir Wellness the share price will likely stay at current levels.
$AVRW early action .039 +21.87% someone accumulating shares this week.
Nice to see AVRW getting more media exposure for the company's growing success story. All real investors should be sure to review this latest feature:
Avenir Wellness / Sera Labs Inc. Partnership with Nicole Kidman - FabFitFun and Influencer Endorsements Drive Sales Growth for Seratoptical Revolutions Skin : Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW)
https://www.einpresswire.com/article/711238053/solid-growth-for-seratoptical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw
In this article:
Proprietary Nutraceutical & Topical Delivery Systems for Wellness and Anti-Aging Beauty Product Lines.
Company Currently Holds 15 Patents.
Seratopical Revolution Skin Care is Personally Used and Endorsed by Global Brand Ambassador & Strategic Partner Nicole Kidman and Other Major Celebrities.
LA-Based Facial Plastic Surgeon Dr. Michael Persky Directly Supporting All Seratopical Revolution Plant-Based Products, Backed by Science with New “Ask the Expert” Videos, Answering Questions Directly from Customers.
Net Revenue in Q4 of 2023 Increased to $1.1 Million or 11.7%, Also Increased Sequentially from Q3 2023 by $43 Thousand, or 4.4%.
Sales Benefits Commencing From New Relationship with Leading Online and Beauty Subscription Box Retailer, FabFitFun.
TICK TOCK - TICK TOCK.......
POM-POMS love posting irrelevant bits of info.
SHOW ME THE MONEY!!!!
IONIC DEFAULTED DEBT!!!
NOBODY WILL FINANCE THIS COMPANY!!!
ONCE AVRW PARTS WAYS WITH RD (COTB)
I WILL "NEVER" POST HERE AGAIN.
IF YOU DON'T SMELL SOMETHING FISHY WITH
RD STILL BEING CHAIRMAN OF THE BOARD OF THIS COMPANY
YOU HAVE NO CLUE WHAT HAS GONE ON HERE.
THIS SHIP IS STILL TAKING ON WATER AND I AM AMAZED IT IS
STILL BEING SUPPORTED BY THOSE WHO ARE UNDERWATER.
JUST A MATTER OF TIME UNTIL IT IS FULLY SUBMERGED.
GOOD LUCK THOUGH.
ANYONE WHO CAN'T UNDERSTAND THAT THERE IS SOMETHING
WRONG HERE WITH THE "RD + ND" COMPANY DUO - UNREAL 🤔
AND ONCE AGAIN - NICOLE KIDMAN HAS BEEN ABOARD FOR OVER
3 YEARS - AND WHAT'S GONE ON? PRICE CONTINUES TO DROP.
$AVRW - Solid Growth for Seratoptical Revolutions Skin Care Line: Boost from Famed FabFitFun & Many Key Celebrities: OTC: AVRW
May 21, 2024
Avenir Wellness Solutions Stock Symbol: AVRW
*Brand Ambassador #NicoleKidman
*Products in FabFitFun
*Seratopical DNA Complex
Avenir Wellness / Sera Labs Inc. Partnership with Nicole Kidman - FabFitFun and Influencer Endorsements Drive Sales Growth for Seratoptical Revolutions Skin : Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW)
https://www.einpresswire.com/article/711238053/solid-growth-for-seratoptical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw
$AVRW on Instagram here:
https://www.instagram.com/reel/CyGgu2pr8zA/?
Avenir Wellness Solutions, Inc. (OTCQB:AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems which are integrated into our wellness and beauty products and sold directly to the consumer. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that is part of its incubator strategy in order to monetize its intellectual property as well as expand our product lines utilizing the technology. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: http://www.avenirwellness.com.
The AVRW news out on Friday contains impressive details on the sales success of the company's products via new marketing outlets...
From the announcement:
Our newly formulated Seratopical Revolution Cracked Heel Souffle was selected for inclusion in FatFitFun's Summer 2024 subscription box selling out an astonishing 80,000 units in under 43 minutes.
Our DNA Complex hero product continues to perform as our subscription based grows.
Wholesale sales led by Amazon continue to grow with all the positive product reviews.
We began development of our new TikTok shop to capitalize on the evolving digital ecommerce landscape which launched in the second quarter of 2024
Not even sure that would help. They burnt through the last
12MM they got in record time - and what did the share price do?
DOWN DOWN DOWN. Once again, they have no clue how to
run a publicly traded company and the debt burden is too large
for them to run it like a basement startup or over the garage
startup. They can't issue shares, they can't get bank loans,
they had a loan shark loan and defaulted on it.
They are destined to fail (JMHO)
On approximately $600.00 in total shares traded.
Not too many people know about this company.
And regardless of what the CEO says in these
BULLSHIT statements - they continue to BLEED
money and NICOLE KIDMAN hasn't made a bit
of difference for over 3 freaking years. So NK
and the tits/ass plastic surgeon fellow - cannot
overcome the massive debt, lawsuit, and lack of
knowledge about how to run a publicly traded
company that this joke of a company is buried
under. As well, RD is STILL Chairman of the Board
which is a HUGE RED FLAG
Anyhow - I stated before that they would come up
with some numbers that would satisfy the SEC and
some of the shareholder's - but it surely wasn't a good
yearly report. (Unless going 2MILL more in debt is a
good thing)
Not receiving the remainder of the patent sale proceeds may have helped however that wasn’t going to move the needle much.
Avenir needs a minimum $10M to $20M from an outside investor or banking firm to significantly boost their sales. If sales remain around $1M quarterly Avenir will eventually go out of business.
Wow up half penny sad! What will it take get to double digits.
From today's AVRW News: We expect accelerating sales will reaffirm the improving overall trajectory of the business. Further, our margin expansion initiatives continue to deliver results with improvement from third quarter, and we continue our overall cost containment initiatives to further reduce SG&A expenses and to maximize operating leverage.
Fine tuning our Search Engine Optimization (SEO), bringing our media buying in house and achieving successful monthly campaigns like theSkimm continue to deliver for us as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO
$AVRW Net revenue in the fourth quarter of 2023 increased to $1.1 million from the same period in 2022 by $0.2 million, or 11.7%
Company goes 2 MILLION more in DEBT !!
$AVRW Filing and Press Release OUT Today! https://www.otcmarkets.com/filing/html?id=17551691&guid=7iQ-kF3pD-GaJth
Good to see the filing was made on time. Let's hope whatever caused this delay has been resolved.
$AVRW NEWS: Avenir Wellness Solutions Reports Fourth Quarter 2023 Results
Press Release | 05/17/2024
New Initiatives Showing Encouraging Results
SHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended December 30, 2023.
Key financial highlights for the fourth quarter included the following:
Net revenue in the fourth quarter of 2023 increased to $1.1 million from the same period in 2022 by $0.2 million, or 11.7%, and also increased sequentially from Q3 2023 by $43 thousand, or 4.4%. Overall growth was lower than expected due to the continued delay in receiving the expected remainder of the asset sale proceeds to be used for advertising and marketing to drive sales. The quarter did, however, benefit from a new relationship with leading online and beauty subscription box retailer, FabFitFun.
Gross margin increased 407 basis points year over year in the fourth quarter of 2023 due to improved working capital management offset in part by a higher proportion of sales coming from our wholesale channel of distribution with its lower margins than our higher-margin direct-to-consumer sales channel.
Gross margin for the third quarter of 2023 decreased sequentially from the second quarter of 2023 by 26 basis points due to a shift in sales channel mix with a higher proportion of wholesale sales to Amazon and FabFitFun which resulted in shipments of approximately $0.3 million.
Cost containment initiatives led to a favorable impact on SG&A expenses (excluding non-cash charges) for the fourth quarter with a decrease of $357 thousand in 2023 compared to 2022 driven by decreased spend on advertising and promotion of $325 thousand lower overhead by $32 thousand.
Net operating loss from continuing operations (excluding non-cash charges) improved by $0.9 million in 2023.
"Our products continue to maintain sales levels which is encouraging given that we have been unable to fully execute on our marketing initiatives pending receipt of the balance of the proceeds from the July 2022 asset sale. As mentioned in our third quarter earnings announcement, the proceeds from the July 2022 asset sale allow us to invest in the future of the Company, but the delay in receiving the balance of the proceeds continued to have an impact on our operating performance. We expect accelerating sales will reaffirm the improving overall trajectory of the business. Further, our margin expansion initiatives continue to deliver results with improvement from third quarter, and we continue our overall cost containment initiatives to further reduce SG&A expenses and to maximize operating leverage.
Fine tuning our Search Engine Optimization (SEO), bringing our media buying in house and achieving successful monthly campaigns like theSkimm continue to deliver for us as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.
Operational Highlights
Other operational highlights during the fourth quarter of 2023 included:
Our newly formulated Seratopical Revolution Cracked Heel Souffle was selected for inclusion in FatFitFun's Summer 2024 subscription box selling out an astonishing 80,000 units in under 43 minutes. Click link to view Instagram videos on our Cracked Heel Souffle.
Our DNA Complex hero product continues to perform as our subscription based grows.
Wholesale sales led by Amazon continue to grow with all the positive product reviews.
We began development of our new TikTok shop to capitalize on the evolving digital ecommerce landscape which launched in the second quarter of 2024.
For further details, please visit our website to review our most recent Form 10-K filed on May 17, 2024 at: http://www.avenirwellness.com/sec-filings/
About Avenir Wellness Solutions, Inc.
Avenir Wellness Solutions, Inc. (OTCQB:AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems which are integrated into our wellness and beauty products and sold directly to the consumer. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that is part of its incubator strategy in order to monetize its intellectual property as well as expand our product lines utilizing the technology. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: www.avenirwellness.com.
About The Sera Labs, Inc.
Sera Labs, a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health and wellness, Sera Labs products are sold direct-to-consumer (DTC) via online website orders, including a subscribe and save option, and also sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers and on Amazon.com. For more information visit: www.seralabshealth.com and follow Sera Labs on Facebook, Instagram and TikTok at @seratopical as well as on X (Twitter) at @sera_labs.
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.
CONTACTS:
Investor Relations
Hanover International Inc.
T: (760) 564-7400
E: investor@avenirwellness.com
SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)
View the original press release on accesswire.com
$AVRW .0439 +13.29% #NEWS OUT!! #OTCQB
I don't see ANY GOOD NEWS at all.
Half of the filing is DISCLAIMERS !!!
Special attention to the following - THE COMPANY CONTINUES TO BLEED TO DEATH...
and the deficit INCREASED by 2 MILLION Dollars !
Working Capital Deficit
Working capital deficit as of December 31, 2023 was approximately $10.5 million, as compared to a working capital deficit of approximately $8.0 million as of December 31, 2022. As of December 31, 2023, current assets were approximately $2.0 million, comprised primarily of (i) cash of approximately $49 thousand, (ii) notes receivable of $1.0 million, (iii) accounts receivable, net of $443 thousand, (iv) inventory, net of $199 thousand, (v) prepaid expenses and other assets of $286 thousand and (vi) due from related party of $4 thousand. As of December 31, 2022, current assets were approximately $5.9 million, comprised primarily of (i) cash of approximately $2.9 million, (ii) notes receivable of $2.0 million, (iii) accounts receivable, net of $232 thousand, (iv) inventory, net of $145 thousand, (v) prepaid expenses and other assets of $441 thousand and (vi) due from related party of $167 thousand.
As of December 31, 2023, current liabilities were approximately $12.5 million, comprised primarily of (i) approximately $8.2 million in loans, notes and convertible notes payable, (ii) approximately $2.5 million in accounts payable; (iii) $416 thousand in deferred revenue, (iv) approximately $1.3 million in accrued expenses, payroll liabilities and sales tax payable, and (v) $45 thousand of operating lease payables. Comparatively, as of December 31, 2022, current liabilities were approximately $13.9 million, comprised primarily of (i) approximately $9.9 million in loans, notes and convertible notes payable, (ii) approximately $1.1 million in accounts payable; (iii) $495 thousand in deferred revenue, (iv) approximately $1.5 million in accrued expenses, payroll liabilities and sales tax payable, (v) contingent stock consideration of $860 thousand and (vi) $124 thousand of operating lease payables.
Very good news today for AVRW - the 10K Annual Report has just been filed on May 17th as can be see on the OTC Markets site here: https://www.otcmarkets.com/filing/html?id=17551691&guid=7iQ-kF3pD-GaJth
This means that the company will be able to maintain its high level OTCQB status and AVRW investors are now provided with the latest real facts about the company's ongoing business development and progress in its business plans. This report covers the period ending on December 31 and we should also soon have another report filed for Q1 of 2024 with even more accountable information for investors who want the real facts.
$AVRW Notification of Late Filing. https://www.otcmarkets.com/filing/html?id=17548408&guid=tcQ-kaY7p9IfJth
I no longer see Avenir Wellness nor SeraLabs in the Building at 5805 Sepulveda #801
It now shows LandMark Network, Inc. Campus location.
Just an FYI....
https://www.google.com/maps/place/5805+Sepulveda+Blvd+%23801,+Van+Nuys,+CA+91411/[@ userid=118].46737,184m/data=!3m2!1e3!4b1!4m6!3m5!1s0x80c297758f8ddf27:0x5f4485e0834aae85!8m2!3d34.176305!4d-118.4667263!16s%2Fg%2F11ll6v272_?entry=ttu
10-9-8-7-6-5-4-3-2-1 DE-LISTING ???
10-9-8-7-6-5-4-3-2-1 HALT / GREY MARKET ?
10-9-8-7-6-5-4-3-2-1 BANKRUPTCY !!
https://fintel.io/sfs/us/avrw#10-K
https://www.avenirwellness.com/sec-filings
MIRACLE ??
$5.79 worth of trading here today - I guess everyone is in way too deep
to bite the bullet now and get their .03-.045 per share before they are
worthless.
BANKRUPTCY or MIRACLE ??
Agreed - won't be long - but as usual it is the shareholder's who get
screwed - ND will still be skating away with Millions of dollars and RD
made sure she would. I'd have to say those two have been "uh hmmm"
some kind of buddies for awhile.
RD himself is the cause of the entire calamity here. And, why would he
still be the Chairman of the Board of directors - unless - he had made some
sweet deal with ND? Imagine that - ND got the 11 Million for SeraLabs which
was the IONIC debt deal - so - CURE could show some income and they could
develop CBD/THC products together - never happened - IONIC default debt -
then somehow RD comes up with 20Mill (that number is still a joke though) to
buy back the manufacturing facility along with the best patents - AND to boot
ND then didn't pay a dime toward the IONIC debt - but - paid back all monies
owed to themselves. Again, you can't make this up - AND a little further, they
burnt through that money in RECORD time. I bet the 10K will have all kind of
made up numbers - that is - if it ever gets released before BANKUPTCY.
You can't make this kind of story up - the tangled web that has been woven.
Anyone who reads this thread would wonder how the hell they are even still
doing any business at all - and why the shareholder's haven't demanded
accountability.......
Just saying - BANKRUPTCY looms.
Can’t wait till last nail in coffin is put in this pig. Fuck this management all suck
Yes sir, the HALT then De-listing appears imminent.
Should be any day now. Buyer Beware - Still no 10K with an excuse
filed in an 8-K which was done wrong so they had to file an 8-K/A.
Anyone still buying in here is quite the gambler.
They have no idea how to run a publicly traded company. NONE
https://www.otcmarkets.com/files/OTCQB_Standards.pdf
Halt - De-listing - BANKRUPTCY
https://fintel.io/sfs/us/avrw#10-K
https://www.avenirwellness.com/sec-filings
There still could be a MIRACLE though ?????
$AVRW @AvenirWellness Leading LA Plastic Surgeon Recommends Seratopical Skin Care for Superior Anti-Aging Performance: (Stock Symbol: AVRW) - World News Report - EIN Presswire https://world.einnews.com/article/688477296/leading-la-plastic-surgeon-recommends-seratopical-skin-care-for-superior-anti-aging-performance-stock-symbol-avrw via @ein_news
OTC MARKETS could halt the trading of this Company in 4 more calendar days if their 10K isn't filed!
Pura Vida!
$AVRW markets the Seratopical Wellness skin care line including the advanced new DNA Complex that work from the inside out to deliver powerful and long lasting anti-aging results. https://seralabshealth.com/
Followers
|
35
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3710
|
Created
|
11/14/16
|
Type
|
Free
|
Moderators ProfitScout Dickmo jedijazz greendolphin11 Student of the Game BlazingStocks |
Avenir Wellness Solutions (OTC: AVRW)
Formerly CURE Pharmaceutical (OTC: CURR)
For more information, please visit: www.avenirwellness.com and www.seralabshealth.com
COMPANY UPDATE:
Press Release | 02/13/2024
Link: https://feeds.issuerdirect.com/news-release.html?newsid=6554360501139897
Brand New Avenir Wellness DNA Product: https://seralabshealth.com/products/dna-complex
CEO INTERVIEW on Apple Podcasts:
"Lifetime of Health and Wellness - Nancy Duitch, CEO The Sera Labs"
Host April Franzino is joined by:
Nancy Duitch, CEO of The Sera Labs (see image below).
"Nancy discusses how she has spent her entire career working on solution-based health, wellness and beauty products to help people look and feel their absolute best."
Instagram: https://www.instagram.com/beautybizshow/
See omnystudio.com/listener for privacy information.
AVENIR WELLNESS: BUILDING INOVATIVE WELLNESS TECHNOLOGIES FOR THE FUTURE
Avenir Wellness is a vertically integrated drug delivery and development company
Committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage
Spokesperson Nicole Kidman, Actor (see image below).
Visit the Seratopical Store on AMAZON
LINK: https://www.amazon.com/stores/SERATOPICAL/page/473637CB-F4D4-470C-B60D-7B3885CDED6E?ref_=ast_bln
The plant based, alcohol-free, non-CBD, anti-aging beauty line is available Wednesday, June 9
Sera Labs, a subsidiary of Avenir Wellness Solutions, announced a new ad campaign and launch of Seratopical Revolution, a new clean, plant-based, technologically advanced, anti-aging, ‘revolutionary,’ beauty line.
Nicole Kidman and Sera Labs Inc., an Avenir Wellness Solutions Company, launch Seratopical Revolution. (Photo: Business Wire)
The line touts 11 luxurious products which are all are made in the U.S., available at accessible pricing, and are designed to make you feel more youthful and hydrated from head to toe. Award-winning actress Nicole Kidman, Sera Labs’ strategic business partner and global brand ambassador, collaborated with Sera Labs to design the Loving Hands Essential Oil , Indulgence Brown Sugar Scrub , Harmony Face & Neck Toner , and Gleaming for the ultimate brightening glow. The full line of products can be seen at Seratopicalrevolution.com .
“I really wanted to create something that was meaningful to me and that I knew people would genuinely enjoy,” said Kidman, Seratopical strategic business partner and global brand ambassador. “These products are personal to me from the scent to the texture. I am so excited to share them with the world and hope everyone loves them as much as we do.”
Seratopical Revolution marries nature and science into one clean and nourishing line of beauty products. The line’s P?P complex, developed by CURE Pharmaceutical, drives natural, plant-based ingredients into the deeper layers of the skin by utilizing a proprietary tri-peptide delivery system. Unlike other companies that use alcohol as a delivery system, which is incredibly drying to the skin, Seratopical Revolution’s natural oil and surfactant delivery systems are efficacious and offer almost immediate results.
“It’s been an incredible ride creating this line with Nicole,” said Nancy Duitch , Sera Labs CEO and CURE Pharmaceutical Chief Strategic Officer. “There are a lot of beauty companies, but the problem is that most of them don’t understand that without an effective delivery system, the products are sitting on top of your skin and clogging your pores. Our proprietary formulators have developed a high-tech delivery system which allows the ingredients to go deep into the skin. Our loyal customers will benefit from scientifically backed ingredients that are designed to enhance hydration and rejuvenate collagen. Revolution offers a full-body line packed with natural plant extracts and peptide blends.”
Seratopical Revolution products can be purchased online at seratopicalrevolution.com
Ad campaign photo and product images: https://www.dropbox.com/sh/o8l39o5xb0yj4bs/AAAj1WTWRwK05EpziP4BJn7ka?dl=0
For more information visit: Seratopical.com , Seralabshealth.com and follow us on Instagram at @seratopical , as well as Twitter , and Facebook . Media contact: press@theseralabs.com .
About Sera Labs
Sera Labs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD and clean plant-based products. Sera Labs creates high quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names Seratopical ™, SeraLabs™, and Gordon’s Herbals™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness. Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direct-to-consumer (DTC), via online website orders, including opt-in subscriptions. For more information visit: Seratopical.com , Seralabshealth.com and follow us on Instagram at @seratopical , as well as Twitter , and Facebook . Media contact: press@theseralabs.com .
About Avenir Wellness Solutions Company
Avenir Wellness is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. As a vertically integrated company, AVRW’s 25,000 square foot, FDA-registered, NSF® cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. Avenir has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210609005442/en/
Avenir Wellness [OTC: AVRW] and Canopy Growth to Produce CBD Oral Thin Films
AVRW has an FDA- and DEA- registered, GMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform™ includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system.
AVRW names Canopy Rivers Chairman John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to the company, most recently serving as chairman of the Canopy Rivers board of directors and former chairman of Canopy Growth’s board of directors.
AVRW offers combined technologies that provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. AVRW partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets. The AVRW company mission is to improve people’s lives by redefining how medicines are delivered and experienced.
AVRW Products Fall Into Two Categories: Nutraceuticals (dietary supplements) and Pharmaceutical Medicines
Nutraceuticals:
CUREfilm® Sleep is a daily dietary supplement that delivers a unique blend of five active ingredients with the CUREfilm® platform to promote healthy sleep patterns. This product is launched in U.S. markets.
CUREfilm® D is a high-potency dietary supplement that provides 50,000 IU of Vitamin D3 delivered with the CUREfilm® platform.
CUREfilm™ Hemp delivers hemp extracts via the CUREfilm® dosage form. This product is launched in U.S. markets.
CUREfilm® β-Caryophyllene is a dietary supplement that contains 30mg of β-Caryophyllene, a powerful terpene known for its anti-inflammatory and analgesic properties.
Pharmaceuticals:
CUREfilm® Blue contains 50mg of Sildenafil delivered with the CUREfilm® platform.
CUREfilm® Canna delivers synthetic and plant-derived cannabinoids in an oral thin film for pharmaceutical indications.
AVRW Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
On February 5th AVRW announced that it had signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s leading pharmaceutical groups specialized in medicinal cannabis products. The agreement grants ReLeaf Europe exclusive access to the AVRW encapsulation technology for certain oral and topical cannabis products in the Netherlands, the world’s first medical cannabis market. ReLeaf Europe products will be the first to use the CUREinside™ quality mark to bolster consumer confidence. Europe is one of the world’s largest medical cannabis markets due to various governments’ approval for medicinal purposes.
ReLeaf Europe is one of the few pharmacy providers of pharmaceutical-grade medicinal cannabis oils in Europe and an ideal partner for the AVRW first step into the European market because of its commitment to establishing clinical evidence and following EU GMP and GDP standards. Through this agreement, AVRW will roll out its powered by CURE strategy that includes exclusive licensing relationships to build global market share.
ReLeaf Europe is tackling the largest market in the world for cannabis by establishing a foothold in Holland — a market estimated to reach $2.6B by 2028 — and by pursuing innovative delivery systems and distribution networks. AVRW will power several ReLeaf Europe products, including one sublingual tincture and two topical creams to be launched in 2020.
Major Earnings Potential in the Emerging Medicinal Cannabis Industry
The Cannabis plant has an estimated 113 different compounds, out of which THC and CBD are the two main constituents. THC is mainly responsible for the psychoactive effects or the
feeling of “high” caused by the use of cannabis. CBD on the other hand, has several powerful anti-inflammatory, analgesic, neuroprotective and anti-anxiety properties, which explains its growing popularity to treat a plethora of medical conditions. Unlike THC, CBD does not have any psychotropic effects and hence is widely preferred.
CBD is now being used to treat a wide array of medical conditions such as cancer, cardiovascular anomalies, arthritis, anxiety, depression and Insomnia. In addition, it has also been proven to possess neuroprotective benefits that can treat diseases such as seizures, Multiple Sclerosis (MS), Alzheimer’s, Parkinson’s and Schizophrenia to name a few. There is a growing preference for CBD over traditional pharmaceutical options as these have minimal side effects and are non-addictive.
The global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand View Research, Inc, growing at a CAGR of 23.9%. There is a growing acceptance of the curative effects of cannabis, with some countries such as Canada and certain states of U.S legalizing the use of Marijuana for medical and recreational use. Research has time and again shown that cannabinoids (CBD), extracted from the cannabis plant, have varied medical uses with minimal side effects, making it a sought-after alternative to traditional pharmaceutical options.
AVRW has signed a licensing and collaboration agreement with
Vanguard Scientific Systems, Inc.
Vanguard is a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, including the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology, as well as industrially scaled CO2 facility solutions. The license gives Vanguard the right to practice CURE’s patented cannabis extraction methods, providing customer confidence in choosing Vanguard’s portfolio of extraction manufacturers
The industry is poised to grow to $2.1 billion in 2020, a 700% increase from 2016. Those numbers are not only appealing to the players in the CBD market but also serve as an incredible opportunity the pharmaceutical companies to create novel solutions for disease with large unmet medical needs. AVRW is strategically positioned with multiple high value assets and extremely well-placed marketing partners to optimize the company’s earnings potential in the growing fields of key drug supply and delivery solutions, including the multi-billion-dollar CBD marketplace. For more information on Avenir Wellness (OTCQB: AVRW ) visit: http://www.avenirwellness.com
Company News
02/13/2024 Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and
Facial Plastic Surgeon Dr. Michael Persky
09/19/2023 Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market
08/08/2023 Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
05/17/2023 Avenir Wellness Solutions Update to Stockholders
04/28/2023 New to The Street Announces the Televised Lineups for Shows 461, 462, and 463; Airings on Three Networks Will Begin on Saturday, April 29, 2023, at 3:30 PM ET
04/26/2023 Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
04/25/2023 Avenir Wellness Letter to Stockholders
04/13/2023 New to The Street Announces the Televised Lineups for Shows 452, 457, and 458, Airings on Three Networks Will Begin Tonight, Thursday, April 13, 2023, at 9:30 PM ET
DISCLAIMER:
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information here.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |